Aptevo Therapeutics Inc. balance sheet

At the end of fiscal 2022, Aptevo Therapeutics Inc. had total assets of $34.2m, total liabilities of $16.2m and shareholders' equity of $18.0m. It held $22.6m in cash against $4.0m of debt: net cash of $18.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Aptevo Therapeutics Inc.: balance sheet, annual
Fiscal year	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022
Cash and equivalents	5	10	7	31	12	40	45	23
Receivables	6	0	2	5	7	—	—	—
Inventory	20	0	1	2	6	—	—	—
Total current assets	35	71	95	49	30	47	53	27
Goodwill	29	—	—	—	—	—	—	—
Total assets	128	92	117	67	53	54	57	34
Accounts payable	10	—	—	12	6	—	—	—
Deferred revenue (current)	4	1	—	—	—	—	—	—
Total current liabilities	20	20	19	18	38	15	35	9
Short-term debt	—	—	3	—	20	5	12	2
Long-term debt	—	18	16	19	—	28	4	1
Total debt	0	18	19	19	39	28	16	4
Total liabilities	39	41	35	37	42	37	55	16
Shareholders' equity	89	51	82	30	12	17	1	18
Net debt (negative = net cash)	−5	9	12	−11	27	−12	−29	−19
Shares outstanding	—	—	—	—	—	—	—	—

US$ millions unless shown otherwise. Fiscal quarters.

Aptevo Therapeutics Inc.: balance sheet, quarterly
Quarter	2021 Q1Mar 2021	2021 Q2Jun 2021	2021 Q3Sept 2021	2021 Q4Dec 2021	2022 Q1Mar 2022	2022 Q2Jun 2022	2022 Q3Sept 2022	2022 Q4Dec 2022
Total current assets	63	66	59	53	42	31	25	27
Total assets	69	71	64	57	45	39	32	34
Total current liabilities	29	31	32	35	24	7	8	9
Short-term debt	10	11	11	12	2	2	2	2
Long-term debt	—	—	—	4	—	—	2	1
Total debt	10	11	11	15	2	2	4	3
Total liabilities	58	58	57	55	51	16	16	16
Shareholders' equity	11	14	7	1	−6	23	16	18
Shares outstanding	4m	5m	5m	5m	5m	5m	5m	6m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Aptevo Therapeutics Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aptevo Therapeutics Inc.